1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsIHI Call 11 is sponsored by Innovative Health Initiative (IHI). A two-stage call launched on 17 June 2025, covering topics such as brain dysfunction, infections linked to non-communicable diseases, pharmacovigilance, type 1 diabetes, and ambulatory surgical centers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
[](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#wtEtransModal "Translate this page")Translate this page This is a machine translation provided by the European Commission’s eTranslation service to help you understand this page. Please read the conditions of use.
* Apply for fundingWhy apply Future opportunities Open calls Closed calls Contribute your own resources to IHI Find partners Call documents * Shape our future researchHow call topics are generated Propose ideas Become a contributing partner * Projects and resultsProject factsheets Maps and Statistics Health spotlights * Resources for projectsEngaging with regulators Exploitation of project results Open science Project communications Project dissemination Project documents * News & eventsNews Events Newsletter * About IHIMission and objectives Research and innovation agenda IHI funding model Who we are Impact History From IMI to IHI Plans, reports and finances [](http://www.
ihi. europa. eu/apply-funding/ihi-call-11#) [](http://www.
ihi. europa. eu/apply-funding/ihi-call-11#my-menu) [](http://www.
ihi. europa. eu/apply-funding/ihi-call-11) IHI call 11 is a two-stage call with topics on brain dysfunction, the link between infections and non-communicable diseases, pharmacovigilance, type 1 diabetes, and ambulatory surgical centres.
* Topic 1: Towards precision medicine: platform for transdiagnostic stratification of brain dysfunction * Topic 2: Understanding how infections foster and induce non-communicable diseases * Topic 3: AI-powered signal detection in pharmacovigilance * Topic 4: Leveraging Europe's expertise to accelerate cell therapy for type 1 diabetes * Topic 5: Establishing ortho and cardiology ambulatory surgical centres in Europe ### Important information on eligibility for funding Applicants should note that legal entities based in the following countries **are not eligible to receive funding for some or all of the topics in this call**.
* **UK and Canada:** Legal entities are eligible to receive funding under topic 1, but not eligible to receive funding under topics 2 to 5. * **Switzerland and South Korea:** Legal entities are not eligible to receive funding under any of the topics in this call. Legal entities based in these countries are of course eligible to participate in the projects as associated partners who participate at their own costs.
Note that legal entities that are not eligible to receive funding cannot serve as coordinator of a project. This is because the funds used for IHI call 11 have been carried over from previous years, when these countries were not associated to Horizon Europe. Under Horizon Europe rules, countries cannot receive funds from budget years prior to their joining the programme.
Topic 1 draws on 2024 funds; as the UK and Canada joined Horizon Europe in 2024, legal entities from these countries are eligible to receive funding. Topics 2-5 draw on funds from 2023 and earlier. As the UK and Canada joined Horizon Europe in 2024, legal entities from these countries are not eligible to receive funding.
Switzerland and South Korea are currently negotiating their association to Horizon Europe. However, even if their association to Horizon Europe is finalised this year, legal entities from these countries will not be able to access funds from previous years, making them ineligible to receive funding under this call. * More information on these issues can be found in the Guide for Applicants (Annex 3) and FAQ (Q5).
The subject was also addressed during the info session on IHI rules and procedures - both the recording and slides from this session are available online. ### Find out more about the topics For full details of the topics, including the budget breakdown, read the**call text**. All documents relating to the call can be found via theFunding and Tenders Portaland theIHI call documents page.
We advise you to read these documents, in particular the guide for applicants, carefully.
### Key dates and deadlines * Draft topic texts published: 10 April, updated 23 May * Call launch: 17 June 2025 * **Short proposal submission deadline: 9 October 2025 at 17:00 Brussels time** * Full proposal submission deadline: 29 April 2026 at 17:00 Brussels time ### Other useful information * Call ID: HORIZON-JU-IHI-2025-11-two-stage | Action type: RIA - Research and Innovation Actions | Call type: Two-stage ### 07 July 2026: Stage 2 evaluation report published IHI has completed the evaluation of the full proposals for IHI call 10.
The results are summarised in this report. ### 17 December 2025: Stage 1 evaluation report published All proposals were assessed for eligibility, and eligible proposals were evaluated by independent experts.
The results of the evaluation are summarised in this report and below: * Number of proposals submitted: 41 * Number of inadmissible proposals: 1 * Number of ineligible proposals: 2 * Number of above-threshold proposals: 5 * Total budget recommended for first ranked proposals admitted to stage 2: EUR 57 410 000 We have informed the applicants of the results of the evaluation and invited the top-ranked consortia to submit a full proposal, together with the industry consortium identified in the call text, by 29 April 2026.
### 15 October 2025: Initial application statistics In total, 41 proposals were submitted in response to this call: Following the eligibility check, all eligible proposals will be evaluated by independent experts. * The maximum financial contribution from IHI JU for these topics is: EUR 57. 4 million * Industry / contributing partner contributions: * Get advice on finding partners.
Proposals must be submitted via the electronic submission system of the Funding and Tenders Portal. To start submitting your proposal, simply click on the relevant topic above - this will take you directly to that topic's page on the portal. Once there, scroll down and click on 'Start submission'.
To submit a proposal via the electronic submission system, you will need to have an EU Login account and ensure that your organisation is registered as a beneficiary.
Additional information and support * Read our guide for applicants plus the other core IHI documents on the call documents page * Catch up on the info sessions from our IHI Call Days for call 11 * Contact the IHI Programme Office * Contact your country's IHI States Representatives Group member or your National Contact Point. Follow us:[](https://www. linkedin.
com/company/innovative-health-initiative/ "Linkedin")[](https://bsky. app/profile/ihieurope. bsky.
social "Bluesky")[](https://mastodon. social/@IHIEurope "Mastodon")[](https://www. youtube.
com/c/TheInnovativeHealthInitiative "YouTube") [](http://www. ihi. europa.
eu/apply-funding/ihi-call-11)Menu * Apply for funding[](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-4) * Shape our future research[](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-6) * Projects and results[](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-8) * Resources for projects[](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-10) * News & events[](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-12) * About IHI[](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-14) [](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-2)Apply for funding * Contribute your own resources to IHI [](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-2)Shape our future research * How call topics are generated * Become a contributing partner [](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-2)Projects and results [](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-2)Resources for projects * Engaging with regulators * Exploitation of project results [](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-2)News & events [](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-2)About IHI * Research and innovation agenda * Plans, reports and finances [](http://www. ihi. europa.
eu/apply-funding/ihi-call-11#mm-15)
According to the current listing, eligibility includes: Organizations established in the EU or countries associated with Horizon Europe, including universities, research organizations, patient organizations, SMEs, and mid-sized companies. Confirm the full requirements in the official notice before applying.
IHI Call 11 is funded by Innovative Health Initiative (IHI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article